Oscar Health, Inc. offers health insurance products and services to individuals, families, and businesses in the United States. The company is headquartered in New York, New York.
| Revenue (TTM) | $15.32B |
| Gross Profit (TTM) | $3.09B |
| EBITDA | $657.96M |
| Operating Margin | 7.96% |
| Return on Equity | 34.30% |
| Return on Assets | 4.47% |
| Revenue/Share (TTM) | $53.60 |
| Book Value | $6.66 |
| Price-to-Book | 4.59 |
| Price-to-Sales (TTM) | 0.64 |
| EV/Revenue | 0.377 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 125.60% |
| Quarterly Revenue Growth (YoY) | 70.40% |
| Shares Outstanding | $273.47M |
| Float | $263.61M |
| % Insiders | 5.16% |
| % Institutions | 73.89% |
Volatility is currently contracting
Oscar Health outshines Molina Healthcare with surging membership, stronger earnings growth prospects, a more attractive valuation and robust stock gains.
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $33.47, representing a -2.48% change from its previous close.
Heico, Cinemark and Oscar Health are three stocks showing relative strength against the broader market.
Oscar Health trades ~13% below its 2021 IPO price, even though management expects 2026 revenue at ~7X its 2021 level. The expiry of enhanced ACA subsidies has always been the main bear case, and it already happened: OSCR grew members ~60% while the ACA market shrank ~13%. For 2027, I see competitor exits, double digit price increases, and consensus EPS below management's own targets as the setup for a rerate.
WOOF, FIVE, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13,52026.
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $34.32, indicating a +1.57% shift from the previous trading day.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Oscar Health's surging revenue, membership gains and improving profitability bolster its growth story, but premium valuation and churn risks cloud its outlook.
Oscar Health raises its 2026 operating earnings outlook to $500M-$700M as pricing gains and tech efficiencies lift margins, despite rising churn and medical costs.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OSCR and any ticker you trade — then tracks every position and per-strategy win rate.
